Cargando…

Role of tumor microenvironment in the efficacy of BCG therapy

Despite its significant overall efficacy, BCG fails to benefit a substantial proportion of bladder cancer (BlCa) patients. Here, we review recent data highlighting the role of tumor microenvironment (TME) in limiting antitumoral activity of BCG treatment and emerging opportunities to target TME to e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, Omar M, Pandey, Ravindra K, Chatta, Gurkamal, Kalinski, Pawel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654968/ https://www.ncbi.nlm.nih.gov/pubmed/33178990 http://dx.doi.org/10.15761/tr.1000170

Ejemplares similares

NFκB-Activated COX2/PGE(2)/EP4 Axis Controls the Magnitude and Selectivity of BCG-Induced Inflammation in Human Bladder Cancer Tissues
por: Ibrahim, Omar M., et al.
Publicado: (2021)

Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance
por: Dolan, Melissa, et al.
Publicado: (2019)

Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemness
por: Liu, Xiaozhuo, et al.
Publicado: (2022)

Role of Immunomodulation of BCG Therapy on AML Remission
por: Kennedy, Alice, et al.
Publicado: (2021)

MyD88-dependent BCG immunotherapy reduces tumor and regulates tumor microenvironment in bladder cancer murine model
por: de Queiroz, Nina M. G. P., et al.
Publicado: (2021)

BCG Aortitis, a Rare Complication of BCG Therapy
por: Haddad, Joseph, et al.
Publicado: (2023)

Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers
por: Ellegate, James, et al.
Publicado: (2022)

Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer
por: Francis, Lily, et al.
Publicado: (2016)

Cost-Effectiveness Analysis of Adjuvant Stage III Colon Cancer Treatment at Veterans Affairs Medical Centers
por: Soni, Amy, et al.
Publicado: (2015)

Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553)
por: Arnold, Susanne M., et al.
Publicado: (2017)

Role of hypoxia in the tumor microenvironment and targeted therapy
por: Chen, Gaoqi, et al.
Publicado: (2022)

Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction
por: Muthuswamy, Ravikumar, et al.
Publicado: (2015)

BCG Vaccination: A Role for Vitamin D?
por: Lalor, Maeve K., et al.
Publicado: (2011)

A randomized phase II study of pazopanib in hormone sensitive prostate cancer: a University of Chicago Phase II Consortium/ Department of Defense Prostate Cancer Clinical Trials Consortium study
por: Ward, James E., et al.
Publicado: (2011)

Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment
por: Menon, Hari, et al.
Publicado: (2019)

Lymphocyte-polarized DC1s: Effective inducers of tumor-specific CTLs
por: Berk, Erik, et al.
Publicado: (2012)

Autophagy Controls BCG-Induced Trained Immunity and the Response to Intravesical BCG Therapy for Bladder Cancer
por: Buffen, Kathrin, et al.
Publicado: (2014)

Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer
por: Kowald, Saskia, et al.
Publicado: (2023)

The role of tumor microenvironment in resistance to anti-angiogenic therapy
por: Ma, Shaolin, et al.
Publicado: (2018)

Role of hypoxia in cancer therapy by regulating the tumor microenvironment
por: Jing, Xinming, et al.
Publicado: (2019)

Challenges to Improve the Stability and Efficacy of an Intravesical BCG Product
por: Hozouri, Hamidreza, et al.
Publicado: (2014)

Modulation of cabozantinib efficacy by the prostate tumor microenvironment
por: Tripathi, Manisha, et al.
Publicado: (2017)

Asymptomatic renal BCG granulomatosis: An unusual complication of intravesical BCG therapy for carcinoma urinary bladder
por: Bhat, Suresh, et al.
Publicado: (2015)

BCG: Disseminated BCG infection: case report
Publicado: (2022)

Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance
por: Deng, Daiyong, et al.
Publicado: (2022)

The role of complement in the tumor microenvironment
por: Ain, Danyaal, et al.
Publicado: (2021)

Antifibrotic therapy to normalize the tumor microenvironment
por: Hauge, Anette, et al.
Publicado: (2020)

Key role of the positive feedback between PGE(2) and COX2 in the biology of myeloid-derived suppressor cells
por: Obermajer, Nataŝa, et al.
Publicado: (2012)

Loss of Lipid Virulence Factors Reduces the Efficacy of the BCG Vaccine
por: Tran, Vanessa, et al.
Publicado: (2016)

Protective Efficacy of BCG Vaccination in Calves Vaccinated at Different Ages
por: Hope, Jayne C., et al.
Publicado: (2023)

The BCG Shortage
por: Messing, Edward M.
Publicado: (2017)

Role of Sphingosylphosphorylcholine in Tumor and Tumor Microenvironment
por: Park, Mi Kyung, et al.
Publicado: (2019)

Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model
por: Xiao, Zhengwen, et al.
Publicado: (2011)

Novel genome polymorphisms in BCG vaccine strains and impact on efficacy
por: Leung, Andrea S, et al.
Publicado: (2008)

BCG Vaccination
Publicado: (1989)

The use of intravesical BCG in urothelial carcinoma of the bladder
por: Alhunaidi, Omar, et al.
Publicado: (2019)

What is the efficacy of BCG vaccination in the protection from COVID-19 in European countries?
por: Ghazvini, K., et al.
Publicado: (2021)

Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG
por: Aceves-Sánchez, Michel de Jesús, et al.
Publicado: (2021)

The role of microenvironment in tumor angiogenesis
por: Jiang, Xianjie, et al.
Publicado: (2020)

Role of MSC in the Tumor Microenvironment
por: Hass, Ralf
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cj3j6c0p31okhcaj9f0na5efk7